Skip to content
healthcare.dev
Get a free key

doxorubicin hydrochloride

NDC 67184-0623, doxorubicin hydrochloride, injection, suspension, liposomal, from Qilu Pharmaceutical Co., Ltd..

Product NDC
67184-0623
Status
Listed
Labeler
Qilu Pharmaceutical Co., Ltd.
Dosage form
INJECTION, SUSPENSION, LIPOSOMAL
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219881
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0623 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXORUBICIN HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Anthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
67184-0623-1671840623011 VIAL, SINGLE-USE in 1 CARTON (67184-0623-1) / 10 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ed634b03-87cf-4a1c-a513-f34196dabd6f

Use it

Look up 67184-0623 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0623 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67184-0623. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.